{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:37:10Z","timestamp":1792291030129,"version":"4.4.0"},"reference-count":81,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001030","name":"National Heart Foundation of Australia","doi-asserted-by":"publisher","award":["104615"],"award-info":[{"award-number":["104615"]}],"id":[{"id":"10.13039\/501100001030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001774","name":"University of Sydney","doi-asserted-by":"publisher","award":["APP1194139"],"award-info":[{"award-number":["APP1194139"]}],"id":[{"id":"10.13039\/501100001774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP2002783"],"award-info":[{"award-number":["APP2002783"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartlungcirc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart, Lung and Circulation"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.hlc.2023.05.018","type":"journal-article","created":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T10:52:29Z","timestamp":1688640749000},"page":"798-807","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Therapeutic Angiogenesis Using Growth Factors After Myocardial Infarction: From Recombinant Proteins to Gene Therapies and Beyond"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0737-7006","authenticated-orcid":false,"given":"Tejas","family":"Deshmukh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.H.","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.hlc.2023.05.018_bib1","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.gheart.2012.10.003","article-title":"Assessing the global burden of ischemic heart disease: part 2: analytic methods and estimates of the global epidemiology of ischemic heart disease in 2010","volume":"7","author":"Forouzanfar","year":"2012","journal-title":"Global Heart"},{"issue":"9859","key":"10.1016\/j.hlc.2023.05.018_bib2","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lozano","year":"2012","journal-title":"Lancet"},{"issue":"17","key":"10.1016\/j.hlc.2023.05.018_bib3","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1016\/j.jacc.2020.03.020","article-title":"Extracellular matrix in ischemic heart disease, part 4\/4: JACC Focus Seminar","volume":"75","author":"Frangogiannis","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.hlc.2023.05.018_bib4","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41569-020-0403-y","article-title":"Myocardial ischaemia\u2013reperfusion injury and cardioprotection in perspective","volume":"17","author":"Heusch","year":"2020","journal-title":"Nat Rev Cardiol"},{"issue":"20","key":"10.1016\/j.hlc.2023.05.018_bib5","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1161\/01.CIR.0000072930.64775.DC","article-title":"Fibrinolysis for acute myocardial infarction: the future is here and now","volume":"107","author":"Armstrong","year":"2003","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.hlc.2023.05.018_bib6","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1056\/NEJMoa1208200","article-title":"Door-to-balloon time and mortality among patients undergoing primary PCI","volume":"369","author":"Menees","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"27","key":"10.1016\/j.hlc.2023.05.018_bib7","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"issue":"15","key":"10.1016\/j.hlc.2023.05.018_bib8","article-title":"National trends in heart donor usage rates: are we efficiently transplanting more hearts?","volume":"10","author":"Dharmavaram","year":"2021","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"8","key":"10.1016\/j.hlc.2023.05.018_bib9","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1242\/dev.111591","article-title":"Developmental origin and lineage plasticity of endogenous cardiac stem cells","volume":"143","author":"Santini","year":"2016","journal-title":"Development"},{"issue":"11","key":"10.1016\/j.hlc.2023.05.018_bib10","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s00011-004-1298-5","article-title":"Chemokines in the ischemic myocardium: from inflammation to fibrosis","volume":"53","author":"Frangogiannis","year":"2004","journal-title":"Inflamm Res"},{"key":"10.1016\/j.hlc.2023.05.018_bib11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fcvm.2019.00025","article-title":"Neutrophils in post-myocardial infarction inflammation: damage versus resolution?","volume":"6","author":"Puhl","year":"2019","journal-title":"Front Cardiovasc Med"},{"issue":"6","key":"10.1016\/j.hlc.2023.05.018_bib12","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1016\/S0002-9440(10)63598-5","article-title":"Myofibroblast and endothelial cell proliferation during murine myocardial infarct repair","volume":"163","author":"Virag","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.hlc.2023.05.018_bib13","article-title":"Myocardial infarction and the immune response\u2014scarring or regeneration? A comparative look at mammals and popular regenerating animal models","volume":"4","author":"Dittrich","year":"2019","journal-title":"J\u00a0Immunol Regen Med"},{"issue":"9","key":"10.1016\/j.hlc.2023.05.018_bib14","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1080\/13543784.2021.1964471","article-title":"Therapeutic angiogenesis in coronary artery disease: a review of mechanisms and current approaches","volume":"30","author":"Narasimhan","year":"2021","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.hlc.2023.05.018_bib15","series-title":"Human physiology. Functions of the Vascular System","first-page":"397","author":"Witzleb","year":"1983"},{"issue":"1","key":"10.1016\/j.hlc.2023.05.018_bib16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/cvr\/cvab047","article-title":"The vasculature: a therapeutic target in heart failure?","volume":"118","author":"Lux\u00e1n","year":"2022","journal-title":"Cardiovasc Res"},{"issue":"4","key":"10.1016\/j.hlc.2023.05.018_bib17","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s40139-020-00215-9","article-title":"beyond growth factors: macrophage-centric strategies for angiogenesis","volume":"8","author":"Nolfi","year":"2020","journal-title":"Curr Pathobiol Rep"},{"issue":"12","key":"10.1016\/j.hlc.2023.05.018_bib18","doi-asserted-by":"crossref","first-page":"5107","DOI":"10.1007\/s00018-021-03831-9","article-title":"Cardiac regenerative capacity: an evolutionary afterthought?","volume":"78","author":"Nguyen","year":"2021","journal-title":"Cell Mol Life Sci"},{"issue":"10","key":"10.1016\/j.hlc.2023.05.018_bib19","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/s41569-018-0079-8","article-title":"Hallmarks of cardiac regeneration","volume":"15","author":"Bertero","year":"2018","journal-title":"Nat Rev Cardiol"},{"issue":"4","key":"10.1016\/j.hlc.2023.05.018_bib20","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.devcel.2016.01.018","article-title":"Mechanisms of cardiac regeneration","volume":"36","author":"Uygur","year":"2016","journal-title":"Dev Cell"},{"key":"10.1016\/j.hlc.2023.05.018_bib21","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3389\/fphys.2017.00238","article-title":"Current understanding of the pathophysiology of myocardial fibrosis and its quantitative assessment in heart failure","volume":"8","author":"Liu","year":"2017","journal-title":"Front Physiol"},{"issue":"1","key":"10.1016\/j.hlc.2023.05.018_bib22","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1161\/CIRCRESAHA.119.311148","article-title":"The extracellular matrix in ischemic and nonischemic heart failure","volume":"125","author":"Frangogiannis","year":"2019","journal-title":"Circ Res"},{"issue":"5","key":"10.1016\/j.hlc.2023.05.018_bib23","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s12265-010-9207-5","article-title":"Protein therapeutics for cardiac regeneration after myocardial infarction","volume":"3","author":"Segers","year":"2010","journal-title":"J\u00a0Cardiovasc Transl Res"},{"issue":"21","key":"10.1016\/j.hlc.2023.05.018_bib24","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1161\/01.CIR.0000102939.04279.75","article-title":"Clinician guide to angiogenesis","volume":"108","author":"Fam","year":"2003","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.hlc.2023.05.018_bib25","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10456-005-9013-x","article-title":"Angiogenesis during exercise and training","volume":"8","author":"Bloor","year":"2005","journal-title":"Angiogenesis"},{"issue":"8","key":"10.1016\/j.hlc.2023.05.018_bib26","doi-asserted-by":"crossref","first-page":"160196","DOI":"10.1098\/rsob.160196","article-title":"High-throughput recombinant protein expression in Escherichia coli: current status and future perspectives","volume":"6","author":"Jia","year":"2016","journal-title":"Open Biol"},{"issue":"6","key":"10.1016\/j.hlc.2023.05.018_bib27","doi-asserted-by":"crossref","first-page":"693","DOI":"10.4155\/tde.12.50","article-title":"Therapeutic angiogenesis: controlled delivery of angiogenic factors","volume":"3","author":"Chu","year":"2012","journal-title":"Ther Deliv"},{"issue":"8","key":"10.1016\/j.hlc.2023.05.018_bib28","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/gt.2016.43","article-title":"Cardiac gene therapy: are we there yet?","volume":"23","author":"Matkar","year":"2016","journal-title":"Gene Ther"},{"issue":"4","key":"10.1016\/j.hlc.2023.05.018_bib29","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0002-9149(03)00661-1","article-title":"One-year follow-up of direct myocardial gene transfer of vascular endothelial growth factor-2 using naked plasmid deoxyribonucleic acid by way of thoracotomy in no-option patients","volume":"92","author":"Fortuin","year":"2003","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.hlc.2023.05.018_bib30","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1161\/CIRCHEARTFAILURE.114.001711","article-title":"Stem cell factor gene transfer improves cardiac function after myocardial infarction in swine","volume":"8","author":"Ishikawa","year":"2015","journal-title":"Circ Heart Fail"},{"issue":"3","key":"10.1016\/j.hlc.2023.05.018_bib31","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1161\/01.CIR.0000153338.47507.83","article-title":"Targeted modification of atrial electrophysiology by homogeneous transmural atrial gene transfer","volume":"111","author":"Kikuchi","year":"2005","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.hlc.2023.05.018_bib32","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S1525-0016(03)00149-7","article-title":"Catheter-based intracoronary myocardial adenoviral gene delivery: importance of intraluminal seal and infusion flow rate","volume":"8","author":"Emani","year":"2003","journal-title":"Mol Ther"},{"issue":"4","key":"10.1016\/j.hlc.2023.05.018_bib33","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1161\/01.CIR.101.4.408","article-title":"Intracoronary adenovirus-mediated delivery and overexpression of the \u03b22-Adrenergic receptor in the heart","volume":"101","author":"Shah","year":"2000","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.hlc.2023.05.018_bib34","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.cardiores.2004.07.003","article-title":"Current status of catheter- and stent-based gene therapy","volume":"64","author":"Sharif","year":"2004","journal-title":"Cardiovasc Res"},{"issue":"1","key":"10.1016\/j.hlc.2023.05.018_bib35","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/1479-5876-9-183","article-title":"Safety and feasibility of percutaneous retrograde coronary sinus delivery of autologous bone marrow mononuclear cell transplantation in patients with chronic refractory angina","volume":"9","author":"Tuma","year":"2011","journal-title":"J\u00a0Transl Med"},{"issue":"6","key":"10.1016\/j.hlc.2023.05.018_bib36","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S0735-1097(03)00915-X","article-title":"Selective pressure-regulated retroinfusion of fibroblast growth factor-2 into the coronary vein enhances regional myocardial blood flow and function in pigs with chronic myocardial ischemia","volume":"42","author":"von Degenfeld","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.hlc.2023.05.018_bib37","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ejheart.2005.10.017","article-title":"Percutaneous endocardial injection of erythropoietin: assessment of cardioprotection by electromechanical mapping","volume":"8","author":"Krause","year":"2006","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"10.1016\/j.hlc.2023.05.018_bib38","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jacbts.2019.07.012","article-title":"First-in-man\u00a0study of a cardiac extracellular matrix hydrogel in early and\u00a0late myocardial infarction patients","volume":"4","author":"Traverse","year":"2019","journal-title":"JACC Basic Transl Sci"},{"issue":"10","key":"10.1016\/j.hlc.2023.05.018_bib39","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/gt.2011.52","article-title":"Delivery of gelfoam-enabled cells and vectors into the pericardial space using a percutaneous approach in a porcine model","volume":"18","author":"Ladage","year":"2011","journal-title":"Gene Ther"},{"issue":"3","key":"10.1016\/j.hlc.2023.05.018_bib40","first-page":"206","article-title":"Nanoparticle-mediated drug delivery system for atherosclerotic cardiovascular disease","volume":"70","author":"Matoba","year":"2017","journal-title":"J\u00a0Cardiol"},{"issue":"1","key":"10.1016\/j.hlc.2023.05.018_bib41","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/10717544.2018.1534898","article-title":"Efficient exosome delivery in refractory tissues assisted by ultrasound-targeted microbubble destruction","volume":"26","author":"Sun","year":"2019","journal-title":"Drug Deliv"},{"issue":"7","key":"10.1016\/j.hlc.2023.05.018_bib42","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.3390\/ijms23073482","article-title":"Progress in bioengineering strategies for heart regenerative medicine","volume":"23","author":"H\u00e4neke","year":"2022","journal-title":"Int J Mol Sci [Internet]"},{"issue":"10","key":"10.1016\/j.hlc.2023.05.018_bib43","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1161\/01.CIR.0000061911.47710.8A","article-title":"The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis","volume":"107","author":"Henry","year":"2003","journal-title":"Circulation"},{"issue":"21","key":"10.1016\/j.hlc.2023.05.018_bib44","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1161\/01.CIR.0000070540.80780.92","volume":"107","author":"Hedman","year":"2003","journal-title":"Circulation"},{"issue":"21","key":"10.1016\/j.hlc.2023.05.018_bib45","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1038\/sj.gt.3302802","article-title":"Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF(121) (AdVEGF121) versus maximum medical treatment","volume":"13","author":"Stewart","year":"2006","journal-title":"Gene Ther"},{"issue":"6","key":"10.1016\/j.hlc.2023.05.018_bib46","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/mt.2009.70","article-title":"VEGF gene therapy fails to improve perfusion of ischemic myocardium in patients with advanced coronary disease: results of the NORTHERN trial","volume":"17","author":"Stewart","year":"2009","journal-title":"Mol Ther"},{"issue":"7","key":"10.1016\/j.hlc.2023.05.018_bib47","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jacc.2004.12.068","article-title":"Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: the Euroinject One trial","volume":"45","author":"Kastrup","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"33","key":"10.1016\/j.hlc.2023.05.018_bib48","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1093\/eurheartj\/ehx352","article-title":"Adenoviral intramyocardial VEGF-D\u0394N\u0394C gene transfer increases myocardial perfusion reserve in refractory angina patients: a phase I\/IIa study with 1-year follow-up","volume":"38","author":"Hartikainen","year":"2017","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.hlc.2023.05.018_bib49","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1161\/hc0802.104407","article-title":"Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial","volume":"105","author":"Simons","year":"2002","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.hlc.2023.05.018_bib50","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1161\/hc1102.105595","article-title":"Angiogenic Gene Therapy (AGENT) trial in patients with stable angina pectoris","volume":"105","author":"Grines","year":"2002","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.hlc.2023.05.018_bib51","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0735-1097(03)00988-4","article-title":"A\u00a0randomized, double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable angina","volume":"42","author":"Grines","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.hlc.2023.05.018_bib52","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jacc.2007.06.010","article-title":"Effects of Ad5FGF-4 in patients with angina: an analysis of pooled data from the AGENT-3 and AGENT-4 trials","volume":"50","author":"Henry","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.hlc.2023.05.018_bib53","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.ahj.2010.11.023","article-title":"Intramyocardial plasmid-encoding human vascular endothelial growth factor A165\/basic fibroblast growth factor therapy using percutaneous transcatheter approach in patients with refractory coronary artery disease (VIF-CAD)","volume":"161","author":"Kuku\u0142a","year":"2011","journal-title":"Am Heart J"},{"issue":"10","key":"10.1016\/j.hlc.2023.05.018_bib54","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/nm1095-1085","article-title":"Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis","volume":"1","author":"Pearlman","year":"1995","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.hlc.2023.05.018_bib55","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.surg.2004.05.017","article-title":"Inhibition of the cardiac angiogenic response to exogenous vascular endothelial growth factor","volume":"136","author":"Voisine","year":"2004","journal-title":"Surgery"},{"issue":"11 Suppl","key":"10.1016\/j.hlc.2023.05.018_bib56","first-page":"I31","article-title":"Functional, cellular, and molecular characterization of the angiogenic response to chronic myocardial ischemia in diabetes","volume":"116","author":"Boodhwani","year":"2007","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.hlc.2023.05.018_bib57","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1161\/01.RES.87.3.207","article-title":"Transgenic myocardial overexpression of fibroblast growth factor-1 increases coronary artery density and branching","volume":"87","author":"Fernandez","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.hlc.2023.05.018_bib58","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.3389\/fphar.2020.01193","article-title":"Basic fibroblast growth factor attenuates injury in myocardial infarction by enhancing hypoxia-inducible factor-1 alpha accumulation","volume":"11","author":"Rao","year":"2020","journal-title":"Front Pharmacol"},{"issue":"117","key":"10.1016\/j.hlc.2023.05.018_bib59","article-title":"Large animal models of heart failure with reduced ejection fraction (HFrEF)","volume":"6","author":"Spannbauer","year":"2019","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"10.1016\/j.hlc.2023.05.018_bib60","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0008-6363(99)00331-4","article-title":"The elusive coypu: the importance of collateral flow and the search for an alternative to the dog","volume":"45","author":"Hearse","year":"2000","journal-title":"Cardiovasc Res"},{"issue":"6","key":"10.1016\/j.hlc.2023.05.018_bib61","first-page":"564","article-title":"Anatomy & distribution of coronary arteries in pig in comparison with man","volume":"127","author":"Sahni","year":"2008","journal-title":"Indian J Med Res"},{"issue":"1","key":"10.1016\/j.hlc.2023.05.018_bib62","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3109\/08941939109140760","article-title":"Porcine model for vascular graft studies","volume":"4","author":"Mehran","year":"1991","journal-title":"J\u00a0Invest Surg"},{"issue":"5","key":"10.1016\/j.hlc.2023.05.018_bib63","first-page":"432","article-title":"A\u00a0comparative anatomic and physiologic overview of the porcine heart","volume":"53","author":"Lelovas","year":"2014","journal-title":"J\u00a0Am Assoc Lab Anim Sci"},{"issue":"11","key":"10.1016\/j.hlc.2023.05.018_bib64","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/nrd1226","article-title":"Therapeutic angiogenesis in cardiovascular disease","volume":"2","author":"Simons","year":"2003","journal-title":"Nat Rev Drug Disc"},{"issue":"11","key":"10.1016\/j.hlc.2023.05.018_bib65","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/cvr\/cvy184","article-title":"Future directions for therapeutic strategies in post-ischaemic vascularization: a position paper from European Society of Cardiology Working Group on Atherosclerosis and Vascular Biology","volume":"114","author":"Caporali","year":"2018","journal-title":"Cardiovasc Res"},{"issue":"10","key":"10.1016\/j.hlc.2023.05.018_bib66","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1161\/01.RES.0000073584.46059.E3","article-title":"VEGF-D Is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses","volume":"92","author":"Rissanen","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.hlc.2023.05.018_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.738325","article-title":"The role of the VEGF family in coronary heart disease","volume":"8","author":"Zhou","year":"2021","journal-title":"Front Cardiovasc Med"},{"issue":"7","key":"10.1016\/j.hlc.2023.05.018_bib68","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrm.2017.27","article-title":"Alternative splicing as a regulator of development and tissue identity","volume":"18","author":"Baralle","year":"2017","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"10.1016\/j.hlc.2023.05.018_bib69","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/cgt.2016.12","article-title":"VEGF121 and VEGF165 differentially promote vessel maturation and tumor growth in mice and humans","volume":"23","author":"Kazemi","year":"2016","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.hlc.2023.05.018_bib70","doi-asserted-by":"crossref","first-page":"672935","DOI":"10.3389\/fcell.2021.672935","article-title":"The multifunctional contribution of fgf signaling to cardiac development, homeostasis, disease and repair","volume":"9","author":"Khosravi","year":"2021","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"10.1016\/j.hlc.2023.05.018_bib71","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.gendis.2017.04.001","article-title":"Adenovirus-mediated gene delivery: potential applications for gene and cell-based therapies in the new era of personalized medicine","volume":"4","author":"Lee","year":"2017","journal-title":"Genes Dis"},{"issue":"10\u201311","key":"10.1016\/j.hlc.2023.05.018_bib72","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/s41434-022-00322-9","article-title":"AAV2-VEGF-B gene therapy failed to induce angiogenesis in ischemic porcine myocardium due to inflammatory responses","volume":"29","author":"Korpela","year":"2022","journal-title":"Gene Therapy"},{"issue":"10","key":"10.1016\/j.hlc.2023.05.018_bib73","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1096\/fj.08-127373","article-title":"Targeting VEGF-encapsulated immunoliposomes to MI heart improves vascularity and cardiac function","volume":"23","author":"Scott","year":"2009","journal-title":"Faseb J"},{"issue":"2","key":"10.1016\/j.hlc.2023.05.018_bib74","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10456-009-9130-z","article-title":"Endogenous endothelial cell signaling systems maintain vascular stability","volume":"12","author":"London","year":"2009","journal-title":"Angiogenesis"},{"issue":"33","key":"10.1016\/j.hlc.2023.05.018_bib75","doi-asserted-by":"crossref","first-page":"13444","DOI":"10.1073\/pnas.1110121108","article-title":"Injectable fibroblast growth factor-2 coacervate for persistent angiogenesis","volume":"108","author":"Chu","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.hlc.2023.05.018_bib76","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s12551-020-00734-0","article-title":"Growth factor therapy for cardiac repair: an overview of recent advances and future directions","volume":"12","author":"White","year":"2020","journal-title":"Biophys Rev"},{"issue":"1","key":"10.1016\/j.hlc.2023.05.018_bib77","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41573-021-00355-6","article-title":"VEGFA mRNA for regenerative treatment of heart failure","volume":"21","author":"Coll\u00e9n","year":"2022","journal-title":"Nat Rev Drug Discov"},{"issue":"10","key":"10.1016\/j.hlc.2023.05.018_bib78","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1093\/cvr\/cvy121","article-title":"Non-coding RNAs in vascular disease - from basic science to clinical applications: scientific update from the Working Group of Myocardial Function of the European Society of Cardiology","volume":"114","author":"Fiedler","year":"2018","journal-title":"Cardiovasc Res"},{"issue":"1","key":"10.1016\/j.hlc.2023.05.018_bib79","doi-asserted-by":"crossref","first-page":"e116","DOI":"10.1371\/journal.pone.0000116","article-title":"MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia","volume":"1","author":"Hua","year":"2006","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.hlc.2023.05.018_bib80","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1161\/CIRCRESAHA.116.305510","article-title":"lncRNA-MIAT regulates microvascular dysfunction by functioning as a competing endogenous RNA","volume":"116","author":"Yan","year":"2015","journal-title":"Circ Res"},{"issue":"10","key":"10.1016\/j.hlc.2023.05.018_bib81","doi-asserted-by":"crossref","DOI":"10.1172\/JCI152308","article-title":"Cardiac pericyte reprogramming by MEK inhibition promotes arteriologenesis and angiogenesis of the ischemic heart","volume":"132","author":"Avolio","year":"2022","journal-title":"J\u00a0Clin Invest"}],"container-title":["Heart, Lung and Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950623005450?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950623005450?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T18:08:19Z","timestamp":1761415699000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1443950623005450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":81,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S1443950623005450"],"URL":"https:\/\/doi.org\/10.1016\/j.hlc.2023.05.018","relation":{},"ISSN":["1443-9506"],"issn-type":[{"value":"1443-9506","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic Angiogenesis Using Growth Factors After Myocardial Infarction: From Recombinant Proteins to Gene Therapies and Beyond","name":"articletitle","label":"Article Title"},{"value":"Heart, Lung and Circulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hlc.2023.05.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}